Global Collaboration to Develop New and Existing Drugs for Neonates
Davis JM, Turner MA. Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA pediatrics. 2015 Oct;169(10):887–8.
Related Posts
-
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy -
Challenges and Opportunities to Enhance Global Drug Development in Neonates
-
Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (including Biological Products) in Neonates -
The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates
-
CPTR’s Relational Sequencing TB Data Platform (ReSeqTB) is highlighted on pages 59 and 60 of UNITAID’s “2015 Tuberculosis Diagnostics Technology and Market Landscape” report.